StockData
Inmune Bio, Inc. logo

Inmune Bio, Inc. (INMB) stock

INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.96+0.01 (+1.44%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Inmune Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Inmune Bio's price to book ratio was 1.5× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 1.3× to 6.0×, with a median of 2.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×−0.1
2025Dec 31, 20251.6×−1.0
2024Dec 31, 20242.7×−1.9
2023Dec 29, 20234.6×+2.8
2022Dec 30, 20221.8×−0.3
2021Dec 31, 20212.1×−3.6
2020Dec 31, 20205.6×+3.1
2019Dec 31, 20192.5×–

More Inmune Bio figures

See a number that looks wrong?